Skip to main content

Acromegaly News

FDA Approves Mycapssa (octreotide) Oral Somatostatin Analog for Acromegaly

NEEDHAM, Mass., June 26, 2020 (GLOBE NEWSWIRE) – Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) approved...

Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

EAST HANOVER, N.J., Dec. 16, 2014 Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor long-acting release (LAR)* (pasireotide) for injectable suspension,...

Ask a question

To post your own question to this support group, sign in or create an account.